Education
About Us
Working with TipRanks
Follow Us
Iteos Therapeutics, Inc. (ITOS)
NASDAQ:ITOS
iTeos Therapeutics (ITOS) Ownership Overview
49.57% Insiders
10.92% Mutual Funds
<0.01% Other Institutional Investors
2.95% ETFs
86.13% Public Companies and
Individual Investors
The ownership structure of iTeos Therapeutics (ITOS) stock is a mix of institutional, retail, and individual investors. Approximately 13.88% of the company’s stock is owned by Institutional Investors, 49.57% is owned by Insiders, and 86.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 16, 2025 | xxxxxxxxxxxxx | $38676437 | |
May 15, 2025 | xxxxxxxxxxxxx | $8317364 | |
May 15, 2025 | xxxxxxxxxxxxx | $5079339 | |
May 15, 2025 | xxxxxxxxxxxxx | $5079339 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $205750 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $2891300 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,688,978 | Insider | 24.18% | 108,065,568 | |
| 3,649,057 | Institution | 8.25% | ― | |
| 3,452,797 | Insider | 7.81% | 34,907,778 | |
| 2,108,594 | Insider | 4.77% | 21,317,885 | |
| 2,108,594 | Insider | 4.77% | 21,317,885 | |
| 1,302,961 | Institution | 2.95% | ― | |
| 1,200,945 | Institution | 2.72% | ― | |
| 660,165 | Institution | 1.49% | ― | |
| 643,864 | Institution | 1.46% | ― | |
| 360,221 | Institution | 0.81% | ― |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,200,945 | Institution | 2.72% | ― | |
| 660,165 | Institution | 1.49% | ― | |
| 643,864 | Institution | 1.46% | ― | |
| 360,221 | Institution | 0.81% | ― | |
| 312,750 | Institution | 0.71% | ― | |
| 278,536 | Institution | 0.63% | ― | |
| 196,582 | Institution | 0.44% | ― | |
| 149,695 | Institution | 0.34% | ― | |
| 148,330 | Institution | 0.34% | ― | |
| 98,850 | Institution | 0.22% | ― |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 753,974 | Institution | 1.71% | 7,645,296 | |
| 710,830 | Institution | 1.61% | 7,186,491 | |
| 301,383 | Institution | 0.68% | 3,056,024 | |
| 258,844 | Institution | 0.59% | 2,616,913 | |
| 224,712 | Institution | 0.51% | 2,271,838 | |
| 142,796 | Institution | 0.32% | 1,447,951 | |
| 139,016 | Institution | 0.31% | 1,405,452 | |
| 113,678 | Institution | 0.26% | 1,149,285 | |
| 107,538 | Institution | 0.24% | 1,087,209 | |
| 82,610 | Institution | 0.19% | 837,665 |
FAQ
Who Owns Iteos Therapeutics, Inc. (ITOS)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 49.57% is held by insiders, and 86.13% is held by retail investors.
What percentage of Iteos Therapeutics, Inc. (ITOS) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Iteos Therapeutics, Inc. (ITOS) stock is held by institutional investors.
What percentage of Iteos Therapeutics, Inc. (ITOS) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.13% of Iteos Therapeutics, Inc. (ITOS) stock is held by retail investors.
Who owns the most shares of Iteos Therapeutics, Inc. (ITOS)?
Ecor1 Capital, Llc owns the most shares of Iteos Therapeutics, Inc. (ITOS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.